GUADALUPI, LIVIA
GUADALUPI, LIVIA
Dipartimento di Medicina dei sistemi
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis
2023-09-12 Bruno, A; Buttari, F; Dolcetti, E; Azzolini, F; Borrelli, A; Lauritano, G; Di Caprio, V; Rizzo, Fr; Gilio, L; Galifi, G; Furlan, R; Finardi, A; Guadalupi, L; Musella, A; Mandolesi, G; Centonze, D; Stampanoni Bassi, M
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis
2024-08-07 Gilio, L; Fresegna, D; Stampanoni Bassi, M; Musella, A; De Vito, F; Balletta, S; Sanna, K; Caioli, S; Pavone, L; Galifi, G; Simonelli, I; Guadalupi, L; Vanni, V; Buttari, F; Dolcetti, E; Bruno, A; Azzolini, F; Borrelli, A; Fantozzi, R; Finardi, A; Furlan, R; Centonze, D; Mandolesi, G
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis
2024-05-14 Guadalupi, L; Vanni, V; Balletta, S; Caioli, S; De Vito, F; Fresegna, D; Sanna, K; Nencini, M; Donninelli, G; Volpe, E; Mariani, F; Battistini, L; Stampanoni Bassi, M; Gilio, L; Bruno, A; Dolcetti, E; Buttari, F; Mandolesi, G; Centonze, D; Musella, A
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients
2024-02-23 Dolcetti, E; Buttari, F; Bruno, A; Azzolini, F; Gilio, L; Di Caprio, V; Lauritano, G; Borrelli, A; Galifi, G; Furlan, R; Finardi, A; Musella, A; Guadalupi, L; Mandolesi, G; Rovella, V; Centonze, D; Stampanoni Bassi, M
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis
2024-07-01 Guadalupi, L; Mandolesi, G; Vanni, V; Balletta, S; Caioli, S; Pavlovic, A; De Vito, F; Fresegna, D; Sanna, K; Vitiello, L; Nencini, M; Tartacca, A; Mariani, F; Rovella, V; Schippling, S; Ruf, I; Collin, L; Centonze, D; Musella, A
Prototypical proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting
2020-01-01 Musella, A; Fresegna, D; Rizzo, Fr; Gentile, A; De Vito, F; Caioli, S; Guadalupi, L; Bruno, A; Dolcetti, E; Buttari, F; Bullitta, S; Vanni, V; Centonze, D; Mandolesi, G
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis
2024-06-07 Sanna, K; Bruno, A; Balletta, S; Caioli, S; Nencini, M; Fresegna, D; Guadalupi, L; Dolcetti, E; Azzolini, F; Buttari, F; Fantozzi, R; Borrelli, A; Stampanoni Bassi, M; Gilio, L; Lauritano, G; Vanni, V; De Vito, F; Tartacca, A; Mariani, F; Rovella, V; Musella, A; Centonze, D; Mandolesi, G
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 12-set-2023 | Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis | Bruno, A; Buttari, F; Dolcetti, E; Azzolini, F; Borrelli, A; Lauritano, G; Di Caprio, V; Rizzo, Fr; Gilio, L; Galifi, G; Furlan, R; Finardi, A; Guadalupi, L; Musella, A; Mandolesi, G; Centonze, D; Stampanoni Bassi, M | Articolo su rivista | |
| 7-ago-2024 | Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis | Gilio, L; Fresegna, D; Stampanoni Bassi, M; Musella, A; De Vito, F; Balletta, S; Sanna, K; Caioli, S; Pavone, L; Galifi, G; Simonelli, I; Guadalupi, L; Vanni, V; Buttari, F; Dolcetti, E; Bruno, A; Azzolini, F; Borrelli, A; Fantozzi, R; Finardi, A; Furlan, R; Centonze, D; Mandolesi, G | Articolo su rivista | |
| 14-mag-2024 | Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis | Guadalupi, L; Vanni, V; Balletta, S; Caioli, S; De Vito, F; Fresegna, D; Sanna, K; Nencini, M; Donninelli, G; Volpe, E; Mariani, F; Battistini, L; Stampanoni Bassi, M; Gilio, L; Bruno, A; Dolcetti, E; Buttari, F; Mandolesi, G; Centonze, D; Musella, A | Articolo su rivista | |
| 23-feb-2024 | Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients | Dolcetti, E; Buttari, F; Bruno, A; Azzolini, F; Gilio, L; Di Caprio, V; Lauritano, G; Borrelli, A; Galifi, G; Furlan, R; Finardi, A; Musella, A; Guadalupi, L; Mandolesi, G; Rovella, V; Centonze, D; Stampanoni Bassi, M | Articolo su rivista | |
| 1-lug-2024 | Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis | Guadalupi, L; Mandolesi, G; Vanni, V; Balletta, S; Caioli, S; Pavlovic, A; De Vito, F; Fresegna, D; Sanna, K; Vitiello, L; Nencini, M; Tartacca, A; Mariani, F; Rovella, V; Schippling, S; Ruf, I; Collin, L; Centonze, D; Musella, A | Articolo su rivista | |
| 1-gen-2020 | Prototypical proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting | Musella, A; Fresegna, D; Rizzo, Fr; Gentile, A; De Vito, F; Caioli, S; Guadalupi, L; Bruno, A; Dolcetti, E; Buttari, F; Bullitta, S; Vanni, V; Centonze, D; Mandolesi, G | Articolo su rivista | |
| 7-giu-2024 | Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis | Sanna, K; Bruno, A; Balletta, S; Caioli, S; Nencini, M; Fresegna, D; Guadalupi, L; Dolcetti, E; Azzolini, F; Buttari, F; Fantozzi, R; Borrelli, A; Stampanoni Bassi, M; Gilio, L; Lauritano, G; Vanni, V; De Vito, F; Tartacca, A; Mariani, F; Rovella, V; Musella, A; Centonze, D; Mandolesi, G | Articolo su rivista |